Delivery Order SPE2DB20D1004-SPE2DB23FG1B3
Award Date
6/21/23
Potential Completion Date
6/22/23
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,112.14, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. This contract is not designated as a set-aside, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,204.70, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,552.65 firm fixed-price contract is for the supply of JANUMET 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,136.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $4,474.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of May 10, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,290.41, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 9, 2024. The contract is not designated with a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,316.00, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of August 3, 2022. This award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.48 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 60S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024 and was awarded on June 25, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,172.43, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of May 20, 2024. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,211.40, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a completion date of February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...